CLINICAL TRIALS PROFILE FOR REGRANEX

All Clinical Trials for REGRANEX

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00034788 ↗	A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX	Terminated	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 3	2000-12-01	The purpose of this study is to evaluate the efficacy and safety of REGRANEX® Gel compared with placebo when applied for up to 52 consecutive weeks to recurring or non-healing ulcers of the ankle or foot related to diabetes.
NCT00389636 ↗	TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers	Unknown status	Solsys Medical LLC	N/A	2006-09-01	Patients will be randomized to receive TheraGauze alone or with Regranex to treat diabetic foot ulcer condition. The purpose of the study is provide the sponsor with pilot information regarding the ability of TheraGauze to promote wound healing on its own and to examine synergy with Regranex in the treatment of diabetic foot ulcers.
NCT00389636 ↗	TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers	Unknown status	Soluble Systems, LLC	N/A	2006-09-01	Patients will be randomized to receive TheraGauze alone or with Regranex to treat diabetic foot ulcer condition. The purpose of the study is provide the sponsor with pilot information regarding the ability of TheraGauze to promote wound healing on its own and to examine synergy with Regranex in the treatment of diabetic foot ulcers.
NCT00446472 ↗	Evaluation of Windowed Casts With and Without Regranex® Gel for Healing Diabetic Neuropathic Ulcers	Unknown status	Heritage Medical Research Institute	N/A	2007-04-01	The objective of this study is to compare the effectiveness and safety of windowed casts with Regranex® (topical becaplermin gel) versus placebo (inactive medication) for treatment of diabetic ulcers on the legs and feet.
NCT00446472 ↗	Evaluation of Windowed Casts With and Without Regranex® Gel for Healing Diabetic Neuropathic Ulcers	Unknown status	Southern California Institute for Research and Education	N/A	2007-04-01	The objective of this study is to compare the effectiveness and safety of windowed casts with Regranex® (topical becaplermin gel) versus placebo (inactive medication) for treatment of diabetic ulcers on the legs and feet.

Clinical Trial Conditions for REGRANEX

Condition Name

Condition Name for REGRANEX
Intervention	Trials
Foot Ulcer	2
Diabetes Mellitus	2
Diabetic Foot	2
Diabetic Foot Ulcers	2

Condition MeSH

Condition MeSH for REGRANEX
Intervention	Trials
Foot Ulcer	6
Diabetic Foot	6
Ulcer	5
Diabetic Neuropathies	2

Clinical Trial Locations for REGRANEX

Trials by Country

Trials by Country for REGRANEX
Location	Trials
India	6
United States	3
France	1

Trials by US State

Trials by US State for REGRANEX
Location	Trials
New York	1
California	1
Illinois	1

Clinical Trial Progress for REGRANEX

Clinical Trial Phase

Clinical Trial Phase for REGRANEX
Clinical Trial Phase	Trials
Phase 3	2
Phase 1/Phase 2	1
Phase 1	1

Clinical Trial Status

Clinical Trial Status for REGRANEX
Clinical Trial Phase	Trials
Completed	4
Unknown status	2
Withdrawn	1

Clinical Trial Sponsors for REGRANEX

Sponsor Name

Sponsor Name for REGRANEX
Sponsor	Trials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	2
Ethicon, Inc.	1
Assistance Publique - Hôpitaux de Paris	1

Sponsor Type

Sponsor Type for REGRANEX
Sponsor	Trials
Industry	8
Other	6
NIH	1